Jamie R. Bhagwan
Cambridge, ENG CB223AT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Human iPSCs: atrial versus ventricular cardiomyocytes and their functional and pharmacological differences.
Journal: Biochemical Society transactions
Published: January 29, 2025
Chamber-specific contractile responses of atrial and ventricular hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development.
Journal: Journal of pharmacological and toxicological methods
Published: February 26, 2024
Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the AAVS1 locus as not an entirely safe harbour.
Journal: F1000Research
Published: May 22, 2020
Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.
Journal: Journal of molecular and cellular cardiology
Published: March 25, 2020
Modeling Hypertrophic Cardiomyopathy: Mechanistic Insights and Pharmacological Intervention.
Journal: Trends in molecular medicine
Published: April 26, 2019
Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits.
Journal: Stem cell reports
Published: September 27, 2018
Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells.
Journal: Stem cells and development
Published: February 07, 2018
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.
Journal: European heart journal
Published: January 12, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026